NATCOPHARM.BONATCOPHARM.BOBSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-14.8%
5Y CAGR-7.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-14.8%/yr
vs +7.1%/yr prior
5Y CAGR
-7.6%/yr
Recent deceleration
Acceleration
-21.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.04B | -14.1% |
| 2024 | $1.21B | +35.8% |
| 2023 | $892.00M | -47.0% |
| 2022 | $1.68B | +18.0% |
| 2021 | $1.43B | -7.6% |
| 2020 | $1.54B | -17.8% |
| 2019 | $1.88B | +46.7% |
| 2018 | $1.28B | +37.5% |
| 2017 | $930.00M | +68.5% |
| 2016 | $552.00M | - |